Lexaria Bioscience Corp.: Lexaria Comments on Study Examining Cannabinoids and SARS-CoV-2

"Cannabinoids have the potential to prevent as well as treat infection by SARS-CoV-2"KELOWNA, BC / ACCESSWIRE / January 18, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or

Related Keywords

Chris Bunka ,Lexaria Bioscience ,George Jurcic ,Richard Van Breeman ,Exchange Commission ,Pfizer ,Lexaria Bioscience Corp ,Company Or Lexaria ,Drug Administration ,Gilead Sciences Inc ,Nasdaq ,Block Cellular Entry ,Lexaria ,Ioscience ,Orp ,Comments ,Study ,Examining ,Cannabinoids ,Cars ,